Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
Patients with IBD are randomized to oral administration of vitamin B5 and placebo based on
the standard treatment, exploring whether Vitamin B5 can increase the clinical remission rate
of IBD patients and improve the treatment effect.